Coarctation of the aorta (CoA) accounts for approximately 5–8% of all congenital heart
defects. Depending on the severity of the CoA and the presence of associated cardiac …

First described in 1760 by the anatomist Morgagni, coarctation of the aorta (CoA) is a
congenital heart defect characterized by narrowing the aorta, typically distal to the left …

Background Coarctation of the aorta (CoA) is a common congenital cardiovascular
malformation, and improvements in the diagnostic process for surgical decision-making are …

BACKGROUND: Covered stent (CS) use for the transcatheter treatment of coarctation of the
aorta (COA) was first described over 20 years ago. The covered Cheatham-platinum stent …

Background Coarctation of the aorta (CoA), a congenital narrowing of the proximal
descending thoracic aorta, is a relatively common form of congenital heart disease …

Background Endovascular treatment of aortic coarctation (CoA) in children and adults
frequently requires stent implantation. The aim of this study was to analyze long‐term results …

Stent implantation has been a promising therapy for congenital heart disease (CHD) due to
better efficacy. Compared to permanent metal stents, bioresorbable polymer stents have …

While coarctation of the aorta varies greatly in both severity and age at presentation, all
patients are at increased risk of hypertension both before and after repair. Despite advances …

Purpose: Endovascular treatment of aortic coarctation (CoA) constitutes a valuable
alternative with low morbidity and mortality. The aim of this systematic review and meta …

Background Coarctation of the aorta (CoA), is a congenital malformation, often combined
with several cardiac abnormalities. At present, the operation effect is satisfactory, but …